Immuneel raises ₹100 crore in Series B funding to expand CAR-T therapy operations and global… EP News Bureau Jun 9, 2026 Immuneel Therapeutics outlines plans to scale manufacturing, advance its cell and gene therapy pipeline, commercialise Qartemi…
